로딩 중…
지수 로딩 중…
Biodyne Co., Ltd.
314930· KOSDAQ· Health Care· Health Care Equipment & Services
₩9,970-7.77%
2026-06-19
Price Chart
Biodyne Co., Ltd.-39.58%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 296.75B KRW |
| Revenue | 6.98B KRW |
| Net Income | 1.97B KRW |
| Total Assets | 44.77B KRW |
| Net Assets | 44.30B KRW |
| Employees | 19 |
| Value | |
| P/E | 150.80x |
| P/B | 6.70x |
| PEG | 0.73x |
| P/S | 42.53x |
| EV/EBITDA | 146.01x |
| FCF Yield | -0.88% |
| Profitability | |
| ROE | 4.44% |
| ROA | 4.40% |
| Op. Margin | 27.93% |
| Revenue Growth | -5.40% |
| Earnings Growth | 207.98% |
| Financial Health | |
| Debt Ratio | 101.06% |
| Total Debt | 0 KRW |
| FCF | -2.60B KRW |
| Cash | 12.22B KRW |
| Current Ratio | 39.77x |
| Net Debt/EBITDA | -6.27x |
| Performance | |
| 1Y Return | -39.58% |
| 1M Return | 3.21% |
| From 52W High | -42.27% |
| 1Y MDD | -42.91% |
| Trading | |
| Volume | 65,059 shares |
| Foreign Own. | 4.21% |
| Per Share | |
| EPS | 49 KRW |
| BPS | 1,503 KRW |
Company Info
Established in 2013, the company develops, manufactures, and sells liquid-based cytology equipment and cancer diagnostic reagent kits, completing a special listing on the KOSDAQ market in 2021. It exports its independently developed blowing technology-based LBC equipment, 'PATHPLORER', and reagent kits to 13 countries, securing patents in multiple nations. The company has an exclusive license agreement with Roche for slide smearing device development, planning to unveil 'VENTANA SP400' in Japan in 2025 and pursue global sales. Biodine is headquartered in Seongdong-gu, Seoul.